Parkinson's Tremor vs Dyskinesia: What's the Difference?
At a Glance
A Parkinson's tremor is typically a rhythmic shaking that occurs when levodopa medication is wearing off. In contrast, levodopa-induced dyskinesia involves fluid, irregular writhing movements that usually happen when medication levels are at their highest.
In this answer
4 sections
When you have Parkinson’s disease, experiencing involuntary movements can be frustrating and confusing. It can be difficult to tell the difference between a Parkinson’s tremor and the twitching that comes from your medications, known as levodopa-induced dyskinesia (LID). The key difference lies in the type of movement and when it happens in relation to your medication schedule. A Parkinson’s tremor is typically a rhythmic shaking that happens when your medication levels are low, while dyskinesia consists of fluid, non-rhythmic, writhing movements that happen when your medication levels are high [1][2].
Understanding these differences is crucial because they mean opposite things for your treatment. A tremor usually means your brain needs more dopamine, while dyskinesia often means your brain is receiving a bit too much dopamine at that moment [2][3]. Important: While tracking these signs is helpful, never adjust your levodopa dosage on your own. Always consult your neurologist before making any changes to your medication schedule.
Recognizing a Parkinson’s Resting Tremor
A resting tremor is a core symptom of Parkinson’s disease [1]. It is often one of the first signs of the condition and indicates that your brain does not have enough dopamine [4][5].
- What it looks like: A tremor is rhythmic and repetitive, like a metronome or a clock ticking. It often looks like “pill-rolling” between your thumb and index finger [1].
- When it happens: It typically occurs when you are at rest, and your limbs are relaxed [1]. The shaking usually decreases or stops completely when you start to use that body part to do something (like reaching for a cup) [6].
- What it means for your medication: Tremors typically happen during your “Off” periods—when the effects of your previous dose of levodopa are wearing off, and the dopamine levels in your blood are dropping [5][7]. This is a sign of under-medication [2]. Note that while levodopa often improves tremors, some resting tremors can be medication-resistant, meaning they may not entirely disappear even when your medication is working well.
Recognizing Levodopa-Induced Dyskinesia (LID)
Dyskinesia is a complication that can develop after you have been taking levodopa for several years [2]. About half of people with Parkinson’s will experience some degree of dyskinesia within five years of starting treatment [8].
- What it looks like: Unlike a rhythmic tremor, dyskinesia is non-rhythmic, fluid, and writhing [1][2]. It can look like fidgeting, dancing, swaying, or twitching [2].
- When it happens: Dyskinesia can happen when you are resting or moving. It is most commonly “peak-dose” dyskinesia, meaning it occurs when your medication is fully kicked in and dopamine levels are at their highest (your “On” period) [9][7]. A less common form, called “diphasic dyskinesia,” can occur specifically as your medication is kicking in or wearing off.
- What it means for your medication: Peak-dose dyskinesia indicates an over-stimulation of dopamine receptors in the brain [10][2]. As Parkinson’s progresses, the “window” of time where your medication works well without causing dyskinesia becomes narrower [11][12].
It is also worth noting that both tremors and dyskinesia can temporarily worsen during times of stress, anxiety, or excitement. This does not necessarily mean your medication has stopped working.
How to Tell Them Apart: A Quick Guide
| Feature | Parkinson’s Resting Tremor | Levodopa-Induced Dyskinesia |
|---|---|---|
| Type of Movement | Rhythmic, regular shaking (like a metronome) [1] | Fluid, irregular, writhing, or twitching (like dancing) [1][2] |
| When it Occurs | At rest, when limbs are relaxed [1] | Anytime, whether resting or moving [2] |
| Medication Timing | “Off” periods (when medication is wearing off) [5] | “On” periods (peak-dose, when medication is strongest) [9][7] |
| Underlying Cause | Too little dopamine (disease baseline) [2] | Too much dopamine stimulation [10][2] |
Managing the Balance
Balancing these two extremes is one of the main goals of Parkinson’s care. If it is incorrectly assumed that dyskinesia is a tremor and a higher medication dose is taken, the dyskinesia will likely worsen. If a tremor is confused for dyskinesia and the medication is reduced, you may experience severe stiffness and slowness.
Doctors manage this tricky balance through several strategies:
- Dose optimization: Taking smaller doses of levodopa more frequently to avoid the high peaks that cause dyskinesia and the low valleys that cause tremors [13][14].
- Extending the medication: Using other oral medications (like COMT or MAO-B inhibitors) or extended-release levodopa to keep dopamine levels smooth and steady [15][3]. For some, continuous levodopa intestinal gels or infusions can be used to prevent fluctuations in medication delivery [13][16].
- Add-on therapies: Some medications, such as amantadine, can specifically target and reduce dyskinesia without worsening your “Off” symptoms [8][3].
- Surgical options: For some, procedures like deep brain stimulation (DBS) can dramatically reduce dyskinesia while controlling tremors [17][18].
Keeping a symptom diary noting the exact times you take your medication and when your movements start and stop will be the most helpful tool for you and your doctor to figure out exactly what kind of movement you are having. A simple entry might look like this:
- 10:00 AM - took levodopa dose.
- 11:15 AM - started swaying and fidgeting while watching TV.
- 1:30 PM - fidgeting stopped, rhythmic shaking in left hand returned.
Common questions in this guide
How can I tell if my shaking is a Parkinson's tremor or dyskinesia?
Does dyskinesia mean my Parkinson's medication stopped working?
Why do I get tremors right before my next dose of levodopa?
Can stress make Parkinson's tremors and dyskinesia worse?
How do doctors treat levodopa-induced dyskinesia?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.Given the specific movements I've recorded in my diary, do they suggest I am experiencing under-medication (tremor) or over-stimulation (dyskinesia)?
- 2.Are my current involuntary movements a sign that my 'therapeutic window' for levodopa is narrowing?
- 3.Could taking smaller, more frequent doses work better for smoothing out my medication levels?
- 4.Would adding an extended-release medication or a specific therapy like amantadine help reduce these fluid movements?
- 5.If these movements are peak-dose dyskinesia, does the severity mean we should discuss alternative delivery methods like infusions or deep brain stimulation (DBS)?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
Related questions
References
References (18)
- 1
Amphiregulin blockade decreases the levodopa-induced dyskinesia in a 6-hydroxydopamine Parkinson's disease mouse model.
Kambey PA, Liu WY, Wu J, et al.
CNS neuroscience & therapeutics 2023; (29(10)):2925-2939 doi:10.1111/cns.14229.
PMID: 37101388 - 2
Levodopa-induced plasticity: a double-edged sword in Parkinson's disease?
Calabresi P, Ghiglieri V, Mazzocchetti P, et al.
Philosophical transactions of the Royal Society of London. Series B, Biological sciences 2015; (370(1672)).
PMID: 26009763 - 3
An Update on Nondopaminergic Treatments for Motor and Non-motor Symptoms of Parkinson's Disease.
Jing XZ, Yuan XZ, Luo X, et al.
Current neuropharmacology 2023; (21(8)):1806-1826 doi:10.2174/1570159X20666220222150811.
PMID: 35193486 - 4
Clinical phenotype and risk of levodopa-induced dyskinesia in Parkinson's disease.
Nicoletti A, Mostile G, Nicoletti G, et al.
Journal of neurology 2016; (263(5)):888-894 doi:10.1007/s00415-016-8075-6.
PMID: 26964541 - 5
Dopamine-responsive and dopamine-resistant resting tremor in Parkinson disease.
Zach H, Dirkx MF, Roth D, et al.
Neurology 2020; (95(11)):e1461-e1470 doi:10.1212/WNL.0000000000010316.
PMID: 32651292 - 6
MDS clinical diagnostic criteria for Parkinson's disease.
Postuma RB, Berg D, Stern M, et al.
Movement disorders : official journal of the Movement Disorder Society 2015; (30(12)):1591-601 doi:10.1002/mds.26424.
PMID: 26474316 - 7
Motor complications in an incident Parkinson's disease cohort.
Scott NW, Macleod AD, Counsell CE
European journal of neurology 2016; (23(2)):304-12 doi:10.1111/ene.12751.
PMID: 26074125 - 8
The Vasomotor Response to Dopamine Is Altered in the Rat Model of l-dopa-Induced Dyskinesia.
Booth S, Ramadan A, Zhang D, et al.
Movement disorders : official journal of the Movement Disorder Society 2021; (36(4)):938-947 doi:10.1002/mds.28357.
PMID: 33135810 - 9
Discovery of levodopa-induced dyskinesia-associated genes using genomic studies in patients and Drosophila behavioral analyses.
Yoon W, Min S, Ryu HS, et al.
Communications biology 2022; (5(1)):872 doi:10.1038/s42003-022-03830-x.
PMID: 36008531 - 10
Excessive firing of dyskinesia-associated striatal direct pathway neurons is gated by dopamine and excitatory synaptic input.
Ryan MB, Girasole AE, Flores AJ, et al.
Cell reports 2024; (43(8)):114483 doi:10.1016/j.celrep.2024.114483.
PMID: 39024096 - 11
Predictors of Levo-dopa induced Dyskinesias in Parkinson's Disease.
Athulya RT, Jayakrishnan S, Iype T, et al.
Annals of Indian Academy of Neurology 2020; (23(1)):44-47 doi:10.4103/aian.AIAN_460_18.
PMID: 32055121 - 12
Motor complications in Parkinson's disease: 13-year follow-up of the CamPaIGN cohort.
Kim HJ, Mason S, Foltynie T, et al.
Movement disorders : official journal of the Movement Disorder Society 2020; (35(1)):185-190 doi:10.1002/mds.27882.
PMID: 31965629 - 13
Levodopa-induced dyskinesia in Parkinson disease: A population-based cohort study.
Turcano P, Mielke MM, Bower JH, et al.
Neurology 2018; (91(24)):e2238-e2243 doi:10.1212/WNL.0000000000006643.
PMID: 30404780 - 14
Levodopa-induced dyskinesia: a historical review of Parkinson's disease, dopamine, and modern advancements in research and treatment.
Hansen CA, Miller DR, Annarumma S, et al.
Journal of neurology 2022; (269(6)):2892-2909 doi:10.1007/s00415-022-10963-w.
PMID: 35039902 - 15
Old Drugs, New Delivery Systems in Parkinson's Disease.
Gupta HV, Lyons KE, Pahwa R
Drugs & aging 2019; (36(9)):807-821 doi:10.1007/s40266-019-00682-9.
PMID: 31161581 - 16
New treatments for levodopa-induced motor complications.
Rascol O, Perez-Lloret S, Ferreira JJ
Movement disorders : official journal of the Movement Disorder Society 2015; (30(11)):1451-60 doi:10.1002/mds.26362.
PMID: 26293004 - 17
Effect of Subthalamic Deep Brain Stimulation on Levodopa-Induced Dyskinesia in Parkinson's Disease.
Kim JH, Chang WS, Jung HH, Chang JW
Yonsei medical journal 2015; (56(5)):1316-21 doi:10.3349/ymj.2015.56.5.1316.
PMID: 26256974 - 18
Pallidal versus subthalamic nucleus deep brain stimulation for levodopa-induced dyskinesia.
Fan SY, Wang KL, Hu W, et al.
Annals of clinical and translational neurology 2020; (7(1)):59-68 doi:10.1002/acn3.50961.
PMID: 31813194
This page provides educational information about distinguishing Parkinson's symptoms from medication side effects. Always consult your neurologist before making any changes to your levodopa dosage or medication schedule.
Get notified when new evidence is published on Parkinson's Disease.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.